Cargando…

Prognostic Impact of Early Changes in Serum Chloride Concentrations Among Hospitalized Acute Heart Failure Patients　― A Retrospective Cohort Study ―

Background: Serum electrolyte concentrations on admission and after the administration of loop diuretics may be associated with prognosis in patients hospitalized due to acute heart failure (AHF). This study investigated the prognostic impact of early changes in chloride (Cl) concentrations after di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Satoshi, Abe, Masami, Iseki, Kunitoshi, Arakaki, Tomohiro, Arasaki, Osamu, Shimabukuro, Michio, Ueda, Shinichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819648/ https://www.ncbi.nlm.nih.gov/pubmed/33693262 http://dx.doi.org/10.1253/circrep.CR-20-0058

Ejemplares similares

Comparison of the prognostic values of three calculation methods for echocardiographic relative wall thickness in acute decompensated heart failure
por: Yamaguchi, Satoshi, et al.
Publicado: (2019)

Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial
por: Ueda, Shinichiro, et al.
Publicado: (2018)

Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus
por: Yamaguchi, Satoshi, et al.
Publicado: (2020)

Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial
por: Teragawa, Hiroki, et al.
Publicado: (2020)

Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial
por: Teragawa, Hiroki, et al.
Publicado: (2022)

Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial
por: Morimoto, Takeshi, et al.
Publicado: (2019)

Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial
por: Morimoto, Takeshi, et al.
Publicado: (2020)

Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
por: Furuhashi, Masato, et al.
Publicado: (2020)

Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial
por: Chihara, Atsuko, et al.
Publicado: (2019)

Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial
por: Hirai, Hiroyuki, et al.
Publicado: (2019)

Correction of serum chloride concentration in dogs with congestive heart failure
por: Adin, Darcy, et al.
Publicado: (2020)

Serum Chloride and Heart Failure
por: Arora, Nayan
Publicado: (2023)

Proposal for heart failure progression based on the ‘chloride theory’: worsening heart failure with increased vs. non‐increased serum chloride concentration
por: Kataoka, Hajime
Publicado: (2017)

Eicosapentaenoic Acid Supplementation Changes Fatty Acid Composition and Corrects Endothelial Dysfunction in Hyperlipidemic Patients
por: Yamakawa, Ken, et al.
Publicado: (2012)

Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study
por: Fujita, Yuko, et al.
Publicado: (2022)

Serial Electrocardiographic Changes in Early Post-myocardial Infarction Pericarditis
por: Hirata, Kazuhito, et al.
Publicado: (2022)

Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
por: Furuhashi, Masato, et al.
Publicado: (2020)

Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy
por: Furuhashi, Masato, et al.
Publicado: (2022)

Prognostic significance of serum chloride level in heart failure patients with preserved ejection fraction
por: Seo, Masahiro, et al.
Publicado: (2022)

The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension
por: Yamaguchi, Satoshi, et al.
Publicado: (2023)

Acute Myocardial Infarction During the Last Part of a Triathlon: A Case Report
por: Yamaguchi, Satoshi, et al.
Publicado: (2022)

Intestinal cholesterol embolism resulting from intra-aortic balloon pumping: a case report
por: Yamaguchi, Satoshi, et al.
Publicado: (2014)

New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population
por: Hirai, Hiroyuki, et al.
Publicado: (2019)

Low fasting plasma glucose level as a predictor of new-onset diabetes mellitus on a large cohort from a Japanese general population
por: Ogata, Emi, et al.
Publicado: (2018)

Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men
por: Shimabukuro, Michio, et al.
Publicado: (2016)

Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
por: Ooshiro, Daisuke, et al.
Publicado: (2017)

Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012
por: Iseki, Kunitoshi
Publicado: (2013)

Nutrition and quality of life in chronic kidney disease patients: a practical approach for salt restriction
por: Iseki, Kunitoshi
Publicado: (2022)

Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Prognostic significance of plasma chloride in elderly patients hospitalized for acute heart failure
por: Llàcer, Pau, et al.
Publicado: (2023)

Fibrin glue patch for pacemaker lead perforation of the right ventricular free wall: A case report
por: Yamaguchi, Satoshi, et al.
Publicado: (2015)

Effusion-Serum Chloride Gradient in Heart Failure-Associated Pleural Effusion　― Pathophysiologic Implications ―
por: Kataoka, Hajime
Publicado: (2020)

A practical approach of salt and protein restriction for CKD patients in Japan
por: Iseki, Kunitoshi, et al.
Publicado: (2016)

CHOLESTEROL AND CHLORIDE IN ACUTE HEART FAILURE
por: Radulović, Bojana, et al.
Publicado: (2019)

Dynamic changes in serum chloride concentrations during worsening of heart failure and its recovery following conventional diuretic therapy: A single‐center study
por: Kataoka, Hajime
Publicado: (2018)

The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry
por: Maruyama, Yukio, et al.
Publicado: (2015)

Improving the safety of high-concentration potassium chloride injection
por: Nakatani, Kaoru, et al.
Publicado: (2019)

Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease
por: Yagi, Shusuke, et al.
Publicado: (2014)

Association of serum chloride concentration with outcomes in postoperative critically ill patients: a retrospective observational study
por: Kimura, Satoshi, et al.
Publicado: (2014)

Sharing knowledge on dialysis registries worldwide
por: Iseki, Kunitoshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_390q8nc97da4pq5tqrot5iqlp8